Aptum is dedicated to assisting companies and academic researchers in the development of vaccines and research antibodies. Our unique software, based on own, patent-pending algorithms, allows to detect most immunogenic regions in the molecule, to define the ability of the peptide or protein fragment to elicit strong humoral or T-cell response. We also evaluate the sequence for its immunological complexity that allows to predict how specific to this particular molecule the immune response will be.